Tiagabine: Recent findings and recommendation regarding dosage;Tiagabina: Aspectos recientes y recomendaciones para su dosificacion

Revista de Neurologia

Volumn 27, Issue 155, 1998, Pages 101-103

  Herranz, J L ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Antiepileptic drugs; Epilepsy; GABA; Tiagabine

Indexed keywords

4 AMINOBUTYRIC ACID; TIAGABINE;

AFFECTIVE NEUROSIS; ASTHENIA; COMPLEX PARTIAL SEIZURE; DEPRESSION; DOSE RESPONSE; DRUG EFFICACY; EPILEPSY; HUMAN; IRRITABILITY; NERVOUSNESS; PHARMACOKINETICS; REVIEW; SIDE EFFECT; TREMOR;

EID: 0032467371     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.27155.98216     Document Type: Review

References (13)

1. Leach JP, Brodie MJ. Tiagabine. Lancet 1998; 351: 203-7.
2. Adkins JC, Noble S. Tiagabine. Drugs 1998; 55: 437-62.
3. Herranz JL. Tiagabina: un antiepiléptico GABAérgico. Rev Neurol 1997; 25: 1607-10.
4. Cato A, Gustavson LE, Qian J, El-Shourbagy T, Kelly EA. Effect of renal impairment on the pharmacokinetics and tolerability of tiagabine. Epilepsia 1998; 39: 43-7.
5. Sachdeo RC, Leroy RF, Krauss GL, Drake ME, Green PM, Leppik IE, et al, for the Tiagabine Study Group. Tiagabine therapy for complex partial seizures. A dose-frequency study. Arch Neurol 1997; 54: 595-601.
6. Uhtman BM, Rowan AJ, Ahmann PA, Leppik IE, Schachter SC, Sommerville KW, et al. Tiagabine for complex partial seizures. A randomized, add-on, dose-response trial. Arch Neurol 1998; 55: 56-62.
7. Bailey V, Schwabe S, Lang H. Experience from 5 large phase IIIB trials with Gabitril: preliminary experiences. Epilepsia 1998; 39 (Suppl 2): S66.
8. Kälviäinen R, Salmenperä T, Jutila L, Riekinnen PJ, Pedersen PC, Perry D, et al. Slow versus fast drug switch from established AED to tiagabine monotherapy. Epilepsia 1998; 39 (Suppl 2): S66.
9. Kälviäinen R, Brodie MJ, Bomhof M, Danta G, Groes L, et al. Long-term TGB monotherapy. Epilepsia 1998; 39 (Suppl 2): S66.
10. Dodrill CB, Amett JL, Sommerville K.W, Shu V. Cognitive and quality of life effects of differing dosages of tiagabine in epilepsy. Neurology 1997; 48: 1025-31.
11. Dodrill CB, Arnett JL, Shu V, Pixton GC, Lenz GT, Sommerville KAV. Effects of tiagabine monotherapy on abilities, adjustment, and mood. Epilepsia 1998; 39: 33-42.
12. Man B, Brodie MJ, Kälviäinen R, Beran R, Berkovic S, Kruse Y, et al. Laboratory variables in a comparative monotherapy drug trial with tiagabine (Gabitnl). Epilepsia 1998; 39 (Suppl 2): S65.
13. Damgaard B, Friis S, Tjong-A-Hung Y. Overdose experience with tiagabine (Gabitril). Epilepsia 1998; 39 (Suppl 2): S65-6.